Panbela Therapeutics Inc Stock
Panbela Therapeutics Inc Stock price
Key metrics
| Market capitalization | $1.60m |
| Enterprise Value | $5.73m |
| P/E (TTM) P/E ratio | 0.00 |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | negative |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-29.72m |
| Free Cash Flow (TTM) Free Cash Flow | $-20.13m |
| Cash position | $60.00k |
Is Panbela Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.
Panbela Therapeutics Inc Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast Panbela Therapeutics Inc:
Analyst Opinions
1 Analyst has issued a forecast Panbela Therapeutics Inc:
Financial data from Panbela Therapeutics Inc
| Jun '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -30 -30 |
52%
52%
|
EBIT (Operating Income) EBIT | -30 -30 |
52%
52%
|
| Net Profit | -29 -29 |
42%
42%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Panbela Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Panbela Therapeutics Inc Stock News
Company Profile
Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The company was founded by Michael Cullen and Thomas Neenan on September 21, 2011 and is headquartered in Waconia, MN.
| Head office | United States |
| CEO | Jennifer Simpson |
| Employees | 8 |
| Founded | 2011 |
| Website | www.panbela.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
